289 related articles for article (PubMed ID: 36918759)
1. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
3. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.
Pan J; Li Y; Wu X; Pan X; Liu C; Zhang H; Wang L; Jiang X; Wang J; Zang N; Pang L; Lv X
J Ethnopharmacol; 2024 Mar; 322():117507. PubMed ID: 38122910
[TBL] [Abstract][Full Text] [Related]
5. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
[TBL] [Abstract][Full Text] [Related]
6. ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.
Zhang J; Wang H; Chen H; Li H; Xu P; Liu B; Zhang Q; Lv C; Song X
Autophagy; 2022 Nov; 18(11):2636-2655. PubMed ID: 35427207
[TBL] [Abstract][Full Text] [Related]
7. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation.
Guo X; Adeyanju O; Olajuyin AM; Mandlem V; Sunil C; Adewumi J; Huang S; Tucker TA; Idell S; Qian G
Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1190-C1200. PubMed ID: 37661917
[TBL] [Abstract][Full Text] [Related]
8. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
9. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts.
Guan R; Yuan L; Li J; Wang J; Li Z; Cai Z; Guo H; Fang Y; Lin R; Liu W; Wang L; Zheng Q; Xu J; Zhou Y; Qian J; Ding M; Luo J; Li Y; Yang K; Sun D; Yao H; He J; Lu W
Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35777761
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
[TBL] [Abstract][Full Text] [Related]
15. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
Deng W; Zhang Y; Fang P; Shi H; Yang S
Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
[TBL] [Abstract][Full Text] [Related]
16. Lung myofibroblast transition and fibrosis is regulated by circ0044226.
Zhang L; Chi X; Luo W; Yu S; Zhang J; Guo Y; Ren Q; Zhang W
Int J Biochem Cell Biol; 2020 Jan; 118():105660. PubMed ID: 31786325
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a.
Sun J; Su W; Zhao X; Shan T; Jin T; Guo Y; Li C; Li R; Zhou Y; Shan H; Sun X; Liang H
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273058
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
Alex L; Tuleta I; Hernandez SC; Hanna A; Venugopal H; Astorkia M; Humeres C; Kubota A; Su K; Zheng D; Frangogiannis NG
Circulation; 2023 Sep; 148(11):882-898. PubMed ID: 37350296
[TBL] [Abstract][Full Text] [Related]
20. Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.
Li X; Ma L; Huang K; Wei Y; Long S; Liu Q; Zhang D; Wu S; Wang W; Yang G; Zhou H; Yang C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]